Answers are grounded in this paper and cite their sources.
The immune system plays a crucial defense-mechanism role by preventing pathogens and various infectious agents from initiating disease [1].Homeostasis in the immune system is maintained by immunostimulation and immunosuppression, leading to immune regulation [2].This defense system classically comprises the two sectors of innate and adaptive immunity [3].In the non-specific defenses, known as innate immunity, neutrophils, macrophages, natural killer (NK) cells, and dendritic cells perceive exogenous factors and promote the production of cytokines [4].When macrophages are activated, they eliminate the hazard directly by phagocytosis and indirectly by releasing inflammatory cytokines such as nitric oxide (NO), prostaglandin E 2 (PGE 2 ), tumor necrosis factor-α (TNF-α), and the interleukins IL-1β and IL-6 [5].In contrast, the specific defenses, known as adaptive immunity, are characterized by T and B cells [6].Inflammatory cytokines are also accompanied by the NF-κB and MAPK signaling pathways [7], which are mediated by toll-like receptors (TLRs) [8].Physiological and pathological responses, including stress responses, inflammation, and apoptosis, are mediated by the MAPK signaling pathway in mammalian cells and tissues [9].In the MAPK signaling pathway, phosphorylation of p38 MAPK and ERK1/2 plays important roles, activating the production of TNF-α, IL-6, and IL-8, which are inflammatory factors [10].Moreover, the MAPK cascade and IL-8 secretion are triggered by .In addition to MAPK, NF-κB regulates the expression of proinflammatory mediators.NF-κB p65 protein combines with IκB protein and exists in the cytoplasm.Depending on external stimuli, NF-κB kinases (IKKs) can phosphorylate the IκB family of proteins, followed by ubiquitination and degradation, further phosphorylating p65 and releasing it into the nucleus, where it promotes inflammation.Cyclophosphamide (CP) is a widely used alkylating cytotoxic agent that exerts broad-spectrum activities in modulating immune responses against various illnesses [1,12].However, administration of high-dose CP can cause immunosuppression and intestinal complications [13].CP-induced immunosuppression decreases the number In this study, we evaluated the immune-enhancing activity of kimchi-derived Lactobacillus plantarum 200655 on immune suppression by cyclophosphamide (CP) in ICR mice.Animals were fed distilled water or 1×10 9 colony-forming unit/kg B.W. 200655 or Lactobacillus rhamnosus GG as a positive control for 14 days.An in vivo model of immunosuppression was induced using CP 150 and 100 mg/kg B.W. at 7 and 10 days, respectively.Body weight, spleen index, spleen weight, and gene expression were measured to estimate the immune-enhancing effects.The dead 200655 (D-200655) group showed an increased spleen weight compared to the sham control (SC) group.Similarly, the spleen index was significantly higher than that in the CP-treated group.The live 200655 (L-200655) group showed an increased mRNA expression of tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-6 in splenocytes.Also, the iNOS and COX-2 mRNA expression was upregulated in the L-200655 group compared to the CP-only (SC) group.The phosphorylation of ERK and MAPK was also upmodulated in the L-200655 group.These results indicate that L. plantarum 200655 ameliorated CP-induced immune suppression, suggesting that L. plantarum 200655 may have the potential to enhance the immune system.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: